Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E P Vichinsky

Showing results (11-20 of 57) with videos related to

Pageof 6
Sort By:
Advances in Pediatrics|August 26, 2000
Major changes in sickle cell diseaseR W Hagar, E P Vichinsky
Pediatric Clinics of North America|May 1, 1980
Unstable hemoglobins, hemoglobins with altered oxygen affinity, and m-hemoglobinsE P Vichinsky, B H Lubin
Pediatric Clinics of North America|May 1, 1980
Sickle cell anemia and related hemoglobinopathiesE P Vichinsky, B H Lubin
Journal of Pediatric Hematology/Oncology|March 3, 1998
Hydroxyurea in children with sickle cell disease: impact on splenic function and compliance with therapyN F Olivieri, E P Vichinsky
The Journal of Pediatrics|May 29, 1998
Correction of the anemia of epidermolysis bullosa with intravenous iron and erythropoietinJ L Fridge, E P Vichinsky
Blood|February 15, 1994
A cautionary note regarding hydroxyurea in sickle cell diseaseE P Vichinsky, B H Lubin
American Journal of Hematology|June 1, 1996
Core decompression in avascular necrosis of the hip in sickle-cell diseaseL A Styles, E P Vichinsky
Journal of Pediatric Hematology/Oncology|February 1, 1996
Ototoxicity in hemoglobinopathy patients chelated with desferrioxamineL A Styles, E P Vichinsky
American Journal of Hematology|January 12, 1999
Deferoxamine treatment during pregnancy: is it harmful?S T Singer, E P Vichinsky
Lancet (London, England)|September 18, 1999
Bone disease in beta-thalassaemiaS T Singer, E P Vichinsky
Pageof 6

Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
Advances in Pediatrics|August 26, 2000
Major changes in sickle cell diseaseR W Hagar, E P Vichinsky
Pediatric Clinics of North America|May 1, 1980
Unstable hemoglobins, hemoglobins with altered oxygen affinity, and m-hemoglobinsE P Vichinsky, B H Lubin
Pediatric Clinics of North America|May 1, 1980
Sickle cell anemia and related hemoglobinopathiesE P Vichinsky, B H Lubin
Journal of Pediatric Hematology/Oncology|March 3, 1998
Hydroxyurea in children with sickle cell disease: impact on splenic function and compliance with therapyN F Olivieri, E P Vichinsky
The Journal of Pediatrics|May 29, 1998
Correction of the anemia of epidermolysis bullosa with intravenous iron and erythropoietinJ L Fridge, E P Vichinsky
Blood|February 15, 1994
A cautionary note regarding hydroxyurea in sickle cell diseaseE P Vichinsky, B H Lubin
American Journal of Hematology|June 1, 1996
Core decompression in avascular necrosis of the hip in sickle-cell diseaseL A Styles, E P Vichinsky
Journal of Pediatric Hematology/Oncology|February 1, 1996
Ototoxicity in hemoglobinopathy patients chelated with desferrioxamineL A Styles, E P Vichinsky
American Journal of Hematology|January 12, 1999
Deferoxamine treatment during pregnancy: is it harmful?S T Singer, E P Vichinsky
Lancet (London, England)|September 18, 1999
Bone disease in beta-thalassaemiaS T Singer, E P Vichinsky
Pageof 6